GLP-2 (Tirzepatide)
Metabolic · 10 mg fill · Research Peptide
A dual GIP and GLP-1 receptor agonist studied in incretin-receptor signaling and pathway-selectivity research.
Overview
Supplied under the label GLP-2, this compound is tirzepatide: a synthetic 39-amino-acid peptide that acts as an agonist at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. A lipid side chain supports reversible albumin binding, which published pharmacokinetic work links to its extended circulating profile. Supplied lyophilized for in-vitro research use.
Specifications
- Composition
- Tirzepatide · dual GIP/GLP-1 receptor agonist (39-aa lipidated peptide)
- Form
- Lyophilized powder
- Vial Size
- 10 mg
- Purity
- >99% (HPLC)
- Reconstitution
- Bacteriostatic water
- Storage
- −20°C · protect from light
- Documentation
- Batch-specific COA
Research applications
- Incretin-receptor (GIPR / GLP-1R) binding assays
- Dual-agonist selectivity and potency comparison
- Receptor-signaling and cAMP-pathway research
- Peptide lipidation and albumin-binding studies
For research use only. This product is intended for laboratory and educational research purposes only. It has not been evaluated by the FDA and is not for human or veterinary consumption, diagnosis, treatment, or cure of any condition.
View in catalogOrdering, vial options and the cart live in the catalog view.